101 related articles for article (PubMed ID: 17294191)
1. A pharmacokinetic study on Z-(+/-)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent.
Al-Ghananeem AM; Albayati ZF; Malkawi A; Sonar VN; Freeman ML; Crooks PA
Cancer Chemother Pharmacol; 2007 Nov; 60(6):915-9. PubMed ID: 17294191
[TBL] [Abstract][Full Text] [Related]
2. Absolute/relative bioavailability and metabolism of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (tetraenes) after intravenous and oral single doses to rats.
Ardjomand-Woelkart K; Kollroser M; Magnes C; Sinner F; Frye RF; Derendorf H; Bauer R; Butterweck V
Planta Med; 2011 Nov; 77(16):1794-9. PubMed ID: 21604240
[TBL] [Abstract][Full Text] [Related]
3. Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study.
Lou Y; Hu H; Liu Y; Yu Q; Li L; Ping L; Yu L; Jiang H; Zeng S
J Pharm Biomed Anal; 2011 Jul; 55(5):1163-9. PubMed ID: 21549539
[TBL] [Abstract][Full Text] [Related]
4. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats.
Kapetanovic IM; Muzzio M; McCormick DL; Thompson TN; Johnson WD; Horn TL; Mohammed A; Rao CV; Kopelovich L
Cancer Chemother Pharmacol; 2012 May; 69(5):1301-6. PubMed ID: 22302406
[TBL] [Abstract][Full Text] [Related]
7. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
[TBL] [Abstract][Full Text] [Related]
9. Intersex effect of lamotrigine on the pharmacokinetic parameters of CDRI-97/78, a novel trioxane antimalarial compound, in rats.
Kushwaha HN; Gautam N; Misra A; Singh B; Kumar S; Siddiqui HH; Singh SK
Arzneimittelforschung; 2012 Jun; 62(6):274-9. PubMed ID: 22508175
[TBL] [Abstract][Full Text] [Related]
10. Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats.
Ren HC; Sun JG; Wang GJ; A JY; Xie HT; Zha WB; Yan B; Sun FZ; Hao HP; Gu SH; Sheng LS; Shao F; Shi J; Zhou F
J Pharm Biomed Anal; 2008 Dec; 48(5):1476-80. PubMed ID: 19022601
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of magnolin in rats.
Kim NJ; Song WY; Yoo SD; Oh SR; Lee HK; Lee HS
Arch Pharm Res; 2010 Jun; 33(6):933-8. PubMed ID: 20607499
[TBL] [Abstract][Full Text] [Related]
12. Disposition, oral bioavailability, and tissue distribution of zearalenone in rats at various dose levels.
Shin BS; Hong SH; Bulitta JB; Hwang SW; Kim HJ; Lee JB; Yang SD; Kim JE; Yoon HS; Kim DJ; Yoo SD
J Toxicol Environ Health A; 2009; 72(21-22):1406-11. PubMed ID: 20077212
[TBL] [Abstract][Full Text] [Related]
13. Oral and i.v. pharmacokinetics of isosteviol in rats as assessed by a new sensitive LC-MS/MS method.
Jin H; Gerber JP; Wang J; Ji M; Davey AK
J Pharm Biomed Anal; 2008 Nov; 48(3):986-90. PubMed ID: 18701231
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality.
Sun J; Zhang L; Song J; Tian S; Huang C; Feng Z; Lv Y; Du G
J Ethnopharmacol; 2013 Jul; 148(2):617-23. PubMed ID: 23707334
[TBL] [Abstract][Full Text] [Related]
15. Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats.
Konsue N; Kirkpatrick J; Kuhnert N; King LJ; Ioannides C
Mol Nutr Food Res; 2010 Mar; 54(3):426-32. PubMed ID: 19866468
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
Zhang Y; Wu H; Wen H; Fang H; Hong Z; Yi R; Liu R
Mar Drugs; 2015 Oct; 13(10):6521-36. PubMed ID: 26512677
[TBL] [Abstract][Full Text] [Related]
17. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, biodistribution and bioavailability of isoliquiritigenin after intravenous and oral administration.
Qiao H; Zhang X; Wang T; Liang L; Chang W; Xia H
Pharm Biol; 2014 Feb; 52(2):228-36. PubMed ID: 24102672
[TBL] [Abstract][Full Text] [Related]
19. Study on bioavailability difference between clopidogrel bisulfate form I and form II using liquid chromatography/tandem mass spectrometry.
Zou QG; Tan XH; Che WJ; Zhang ZJ; Wei P; Ou-Yang PK
Arzneimittelforschung; 2011; 61(6):353-7. PubMed ID: 21827046
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of the novel, synthetic trioxane antimalarial compound 97-78 in rats using an LC-MS/MS method for quantification.
Singh RP; Sabarinath S; Gautam N; Gupta RC; Singh SK
Arzneimittelforschung; 2011; 61(2):120-5. PubMed ID: 21428247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
